We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Development of the Cutaneous Dermatomyositis Investigator Global Assessment (CDM-IGA): A De Novo IGA of Cutaneous Manifestations of Dermatomyositis

    Introduction

    Dermatomyositis (DM) is a rare systemic autoimmune disease characterized by a distinctive debilitating skin rash and skeletal muscle...

    Stephanie McKee, Jason Xenakis, ... Sarah L. Knight in Dermatology and Therapy
    Article Open access 08 July 2024
  2. Trends by race and ethnicity in incidence and mortality of acral lentiginous melanoma: analysis of Surveillance, Epidemiology, and End Results 2000–2020

    Limited data describe the epidemiology and risk factors of acral lentiginous melanoma (ALM). In this retrospective analysis, we examined trends in...

    Brandon Ansbro, Julia M. Riley in Archives of Dermatological Research
    Article 05 July 2024
  3. Global burden of skin and subcutaneous diseases and its association with socioeconomic status in children and adolescents: an analysis of the Global Burden of Diseases Study 2019

    Skin and subcutaneous diseases are one of the most common problems affecting the health of children and adolescents. The purpose of this study was to...

    Meina Lv, Bin Zheng in Archives of Dermatological Research
    Article 05 July 2024
  4. Tirbanibulin decreases cell proliferation and downregulates protein expression of oncogenic pathways in human papillomavirus containing HeLa cells

    Tirbanibulin 1% ointment is a synthetic antiproliferative agent approved in 2021 by the European Union for treating actinic keratoses (AK). Topical...

    Stephen Moore, Veda Kulkarni, ... Stephen K. Tyring in Archives of Dermatological Research
    Article 05 July 2024
  5. Comparison of efficacy and safety of tofacitinib and azathioprine in patients with alopecia areata and variants: a double-blind, randomized controlled trial

    Background

    Alopecia areata (AA) is an autoimmune pathology manifested by loss of hair.

    Objective

    To evaluate and compare the efficacy and safety of...

    Majid Paracha, Muhammad Wasim, ... Iftikhar Ahmad in Archives of Dermatological Research
    Article 05 July 2024
  6. Skin color reporting in basal cell carcinoma-related randomized controlled trials in top dermatology journals: a systematic review

    Objectives: To determine the rate skin color is reported in randomized controlled trials (RCTs) involving basal cell carcinoma (BCC) identification...

    Natasha L. Salmen, Deven P. Curtis, ... Robert T. Brodell in Archives of Dermatological Research
    Article Open access 05 July 2024
  7. Exploring the role of vitamin D-VDR pathway in pemphigus foliaceous: a novel perspective on disease pathogenesis

    Several auto-immune diseases have been linked to vitamin D deficiency as a contributing environmental factor. Its pleiotropic effects on the immune...

    Safa Tahri, Nesrine Elloumi, ... Olfa Abida in Archives of Dermatological Research
    Article 03 July 2024
  8. Hair Shaft Abnormalities as a Dermoscopic Feature of Mycosis Fungoides: Pilot Results

    Introduction

    Diagnosis of persistent erythematous, scaly patches, or plaques can be complex since psoriasis (Ps), eczematous dermatitis (ED), and...

    Magdalena Jasińska, Joanna Czuwara, ... Adriana Rakowska in Dermatology and Therapy
    Article Open access 03 July 2024
  9. Antitumor activity of anlotinib in malignant melanoma: modulation of angiogenesis and vasculogenic mimicry

    Malignant melanoma presents a formidable challenge due to its aggressive metastatic behavior and limited response to current treatments. To address...

    Qian Yang, Qianqian Li, Hua Fan in Archives of Dermatological Research
    Article 03 July 2024
  10. Hidradenitis suppurativa and psychosocial well-being: a cross-sectional survey analysis from the All of Us research program

    Hidradenitis suppurativa (HS) is a chronic inflammatory cutaneous disease that often leads to decreased quality of life. Prior research assessing...

    Shivani Jain, Sokol Tushe, ... Lauren A.V. Orenstein in Archives of Dermatological Research
    Article 02 July 2024
Did you find what you were looking for? Share feedback.